URYPAB traded at 0.0250680 this Friday March 20th, increasing 0.0003909 or 1.58 percent since the previous trading session. Looking back, over the last four weeks, URYPAB gained 2.72 percent. Over the last 12 months, its price rose by 5.74 percent. Looking ahead, we forecast URYPAB to be priced at 0.0247771 by the end of this quarter and at 0.0250913 in one year, according to Trading Economics global macro models projections and analysts expectations.